Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integer HoldingsITGR -0.01%85 EV-to-EBIT is 33.41 as of Aug. 22, 2026, which is 18% above its 10-year median of 28.22. GuruFocus rates ITGR with a GF Score™ of 85/100 and a GF Value™ of $122.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 473 Medical Devices & Instruments companies, Integer Holdings ranks worse than 73.78% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Integer Holdings's Enterprise Value for the quarter that ended in Jun. 2026 was $4,520 Mil.
Integer Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $168 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integer Holdings EV-to-EBIT Related Terms
Integer Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Integer Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Integer Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integer Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Integer Holdings's EV-to-EBIT falls into.
Integer Holdings's current Enterprise Value is $5,599 Mil.
Integer Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $168 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integer Holdings (ITGR) has a EV-to-EBIT of 33.41 as of Aug. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Integer Holdings and its competitors. This is 18% above median its historical median of 28.22. Over the past decade, Integer Holdings' EV-to-EBIT has ranged from 15.45 to 66.53. According to the industry distribution chart, Integer Holdings ranks #349 out of 473 companies in the Medical Devices & Instruments industry, placing it in the top 73.8%.
Is Integer Holdings' EV-to-EBIT too high?
Integer Holdings' current EV-to-EBIT of 33.41 is 18% above median its 10-year median of 28.22. Over the past 10 years, this metric has ranged from a low of 15.45 to a high of 66.53. The Medical Devices & Instruments industry median EV-to-EBIT is 18.87. Integer Holdings' value of 33.41 is 77.1% above this industry median. Based on the distribution chart, Integer Holdings ranks #349 out of 473 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Integer Holdings has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integer Holdings' EV-to-EBIT compare to HAE and IRTC?
According to the Medical Devices & Instruments industry distribution chart, Integer Holdings ranks #349 out of 473 companies for EV-to-EBIT. This places Integer Holdings in the lower half of its industry. The industry median EV-to-EBIT is 18.87. Integer Holdings' value of 33.41 is 77.1% above this benchmark. Historically, Integer Holdings' own EV-to-EBIT has ranged from 15.45 to 66.53 over the past decade. While the company's 10-year median is 28.22 vs. the industry median of 18.87, Integer Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.87, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integer Holdings's current EV-to-EBIT of 33.41 is 77.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Integer Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integer Holdings's current EV-to-EBIT is 33.41, which is 18% above median its own 10-year median of 28.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integer Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integer Holdings (ITGR) is currently considered Fairly Valued. The stock's GF Value™ is $122.05, compared to a current price of $125.20 — trading 2.6% above its estimated fair value. The current EV-to-EBIT is 33.41, which is 18% above median its 10-year median of 28.22 and 77.1% above the Medical Devices & Instruments industry median of 18.87. Integer Holdings' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Integer Holdings (ITGR), the current EV-to-EBIT is 33.41 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integer Holdings (ITGR) Overvalued in 2026?
Based on GuruFocus' analysis, Integer Holdings stock appears to be overvalued.
The current stock price of $125.20 is trading 2.6% above its estimated GF Value™ of $122.05.
GuruFocus considers Integer Holdings to be Fairly Valued.
Key valuation signals for ITGR:
EV-to-EBIT: 33.41 (18% above median its 10-year median of 28.22)
GF Value™: $122.05 vs. price of $125.20 (2.6% above fair value)
Industry Position: 77.1% above the Medical Devices & Instruments median (#349 of 473)
No single metric tells the full story. See the ITGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
85GF Score
Get the complete analysis for ITGR
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ITGR has been successfully added to your 
